World's Best Scientists 2026 revealed!
Olivier Cussenot

Olivier Cussenot

D-Index & Metrics

Medicine

D-Index
90
Citations
30378
World Ranking
12187
National Ranking
380

Overview

Olivier Cussenot is affiliated with Université Paris Cité in France and has a research portfolio focused primarily on medicine and biochemistry, genetics, and molecular biology. Their scientific work spans multiple subfields, including pulmonary and respiratory medicine, surgery, molecular biology, oncology, and genetics.

Their research frequently addresses topics related to prostate and bladder cancers, with particular attention to treatment and diagnosis. Main themes in their publications include prostate cancer treatment and research, prostate cancer diagnosis and treatment, bladder and urothelial cancer treatments, urinary and genital oncology studies, genetic factors in colorectal cancer, genetic associations and epidemiology, and molecular biology techniques and applications.

Olivier Cussenot has collaborated consistently with several coauthors, including Géraldine Cancel-Tassin, Éva Compérat, Morgan Rouprêt, Rosalind A. Eeles, and Zsofia Kote-Jarai, highlighting a collaborative research approach in their field.

Their recent publications include:

  • European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel, 2021, European Urology
  • Clinical practice guidelines for BRCA1 and BRCA2 genetic testing, 2021, European Journal of Cancer
  • Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer, 2021, Modern Pathology
  • Screening, diagnosis and monitoring of sarcopenia: When to use which tool?, 2022, Clinical Nutrition ESPEN
  • Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel Study, 2021, European Urology Oncology

The venues where Olivier Cussenot frequently publishes include Progrès en Urologie, European Urology Oncology, UNC Libraries, European Urology, and the World Journal of Urology. These venues reflect the clinical and research-oriented nature of their work, particularly in urology and oncology-related topics.

Best Publications

  • REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants

    Nilah M M. Ioannidis;Joseph H H. Rothstein;Joseph H H. Rothstein;Vikas Pejaver;Sumit Middha

  • Genome-wide association study of prostate cancer identifies a second risk locus at 8q24

    Meredith Yeager;Nick Orr;Richard B Hayes;Kevin B Jacobs

  • Multiple loci identified in a genome-wide association study of prostate cancer

    Gilles Thomas;Kevin B Jacobs;Meredith Yeager;Meredith Yeager;Peter Kraft

  • Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

    Fredrick R. Schumacher;Ali Amin Al Olama;Sonja I. Berndt;Sara Benlloch

  • A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci

    Nathaniel Rothman;Montserrat Garcia-Closas;Nilanjan Chatterjee;Nuria Malats

  • Predisposing Gene for Early-Onset Prostate Cancer, Localized on Chromosome 1q42.2-43

    Philippe Berthon;Antoine Valeri;Annick Cohen-Akenine;Eric Drelon

  • Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

    David V. Conti;Burcu F. Darst;Lilit C. Moss;Edward J. Saunders

  • Olfactory detection of prostate cancer by dogs sniffing urine: a step forward in early diagnosis.

    Jean-Nicolas Cornu;Géraldine Cancel-Tassin;Valérie Ondet;Caroline Girardet

  • Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays.

    Alain Latil;Ivan Bièche;Dominique Vidaud;Rosette Lidereau

  • Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3

    Mark P. Purdue;Mattias Johansson;Diana Zelenika;Jorge R. Toro

  • Identification of a new prostate cancer susceptibility locus on chromosome 8q24

    Meredith Yeager;Meredith Yeager;Nilanjan Chatterjee;Julia Ciampa;Kevin B Jacobs

  • A Systematic Review and Meta-analysis of Clinicopathologic Factors Linked to Intravesical Recurrence After Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma

    Thomas Seisen;Benjamin Granger;Pierre Colin;Priscilla Léon

  • European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel.

    Richard J. Sylvester;Oscar Rodríguez;Virginia Hernández;Diana Turturica

  • VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms.

    A. Latil;I. Bièche;S. Pesche;A. Valéri

  • HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG)

    Jianfeng Xu;Ethan M. Lange;Ethan M. Lange;Lingyi Lu;Siqun L. Zheng

  • Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways.

    Alain G. Latil;Rahmène Azzouzi;Géraldine S. Cancel;Emmanuelle C. Guillaume

  • Mid-term evaluation of the transobturator male sling for post-prostatectomy incontinence: focus on prognostic factors.

    Jean-Nicolas Cornu;Philippe Sèbe;Calin Ciofu;Laurence Peyrat

  • Upper Urinary Tract Urothelial Cell Carcinomas and Other Urological Malignancies Involved in the Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) Tumor Spectrum

    Morgan Rouprêt;David R. Yates;Eva Comperat;Olivier Cussenot

  • Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old.

    Eva Compérat;Stéphane Larré;Morgan Roupret;Yann Neuzillet

  • Genome-wide association study of prostate cancer identifies a second risk locus at 8q24

    Adam S. Kibel

Frequent Co-Authors

Morgan Rouprêt
Morgan Rouprêt Université Paris Cité
Eva Comperat
Eva Comperat Sorbonne University
Stephen J. Chanock
Stephen J. Chanock National Institutes of Health
Graham G. Giles
Graham G. Giles University of Melbourne
David J. Hunter
David J. Hunter Harvard University
Demetrius Albanes
Demetrius Albanes National Institutes of Health
Meredith Yeager
Meredith Yeager Hood College
Janet L. Stanford
Janet L. Stanford Fred Hutchinson Cancer Research Center
Peter Kraft
Peter Kraft Harvard University
Susan M. Gapstur
Susan M. Gapstur American Cancer Society

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring the medical field doesn’t always mean following the traditional path of an MD. Many students are now considering flexible online programs to enhance their credentials and expand career opportunities in healthcare.

For nurses seeking advanced roles, msn to dnp programs online provide a convenient route to a doctorate in nursing practice. Pharmacy is another vital field—students interested in medications and patient care can consider pursuing studies at a best online pharmacy school.

The healthcare industry also needs professionals skilled in data and information management. Accredited health information technology programs online teach students how to manage medical records, ensure data accuracy, and uphold patient privacy.

For those seeking entry-level roles, medical billing and coding online courses open doors to administrative careers within hospitals, clinics, and insurance firms. Each of these online learning options offers flexible, affordable paths to rapidly-growing healthcare jobs.

Best Scientists Citing Olivier Cussenot

Trending Scientists